Patents/Inventors

Richard E. Olson

Cambridge, MAUS12 patents

13 Patents

US124921722025
Substituted Quinazolinyl Compounds Useful as T Cell Activators
Bristol-myers Squibb Company
0 cites
US124545312025
Substituted Piperazine Derivatives Useful as T Cell Activators
Bristol-myers Squibb Company
0 cites
US122410652025
Antisense Oligonucleotides Targeting Alpha-synuclein and Uses Thereof
Roche Innovation Center Copenhagen A/S
0 cites
US121804782024
Antisense Oligonucleotides Targeting Alpha-synuclein and Uses Thereof
Roche Innovation Center Copenhagen A/S
0 cites
US121631312024
Oligonucleotides for Modulating Tau Expression
Hoffmann-la Roche Inc.
0 cites
US120775582024
Phosphorus (v)-based Reagents, Processes for the Preparation Thereof, and Their Use in Making Stereo-defined Organophosphorus (V) Compounds
The Scripps Research Institute
0 cites
US119649732024
Substituted Bicyclic Compounds Useful as T Cell Activators
Bristol-myers Squibb Company
0 cites
US118664302024
Naphthyridinone Compounds Useful as T Cell Activators
Bristol-myers Squibb Company
0 cites
US117619512023
Methods of Selecting Therapeutic Molecules
BRISTOL-MYERS SQUIBB COMPANY
0 cites
US117536402023
Oligonucleotides for Modulating Tau Expression
Hoffmann-la Roche Inc.
0 cites
US117133162023
Substituted Naphthyridinone Compounds Useful as T Cell Activators
Bristol-myers Squibb Company
0 cites
US116135542023
Phosphorous (v)-based Reagents, Processes for the Preparation Thereof, and Their Use in Making Stereo-defined Organophoshorous (V) Compounds
The Scripps Research Institute
0 cites
US115847472023
Substituted Pyridopyrimidinonyl Compounds Useful as T Cell Activators
0 cites